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Motivation
Viruses have caused many epidemics throughout human history. The novel coronavirus [10] is
just the latest example. A new viral outbreak can be unpredictable, and development of specific
defense tools and countermeasures against the new virus remains time-consuming even in today's
era of modern medical science and technology. In the lack of effective and specific medication or
vaccination, it would be desirable to have a nonspecific protocol or substance to render the virus
inactive, a substance/protocol, which could be applied whenever a new viral outbreak occurs. This
is especially important in cases when the emerging new virus is as infectious as SARS-CoV-2 [4].
Aim and structure of the present communication
In this editorial, we propose to consider the possibility of developing and implementing antiviral
protocols by applying high purity aqueous chlorine dioxide (ClO2) solutions. The aim of this
proposal is to initiate research that could lead to the introduction of practical and effective
antiviral protocols. To this end, we first discuss some important properties of the ClO2 molecule,
which make it an advantageous antiviral agent, then some earlier results of ClO2 gas applicationpCorresponding author: Prof. emer. Laszlo Rosivall, MD, PHD, DSc, FERA, FAPS, Institute of Translational
Medicine, International Nephrology Research and Training Center, Semmelweis University, Budapest, Nagyvarad
ter 4., H-1089, Hungary. Tel/Fax: 36-1-2100-100, E-mail: rosivall.laszlo@med.semmelweis-univ.hu
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viral infections using aqueous ClO2 solutions.PREVIOUS EXPERIENCE AND BACKGROUND OF USING ClO2 AS AN
ANTIVIRAL AGENT
Inactivating viruses with ClO2 in aqueous phase
To our present knowledge, an aqueous solution of ClO2 is able to inactivate all types of viruses.
Disinfectants (in water phase) are compared by their CT values, which is the concentration
(measured in mg/L) multiplied by the contact time (measured in minute). In CT tables, ClO2 is
indicated for viruses in general, without mentioning any exemptions. For example, according to
[6], a CT value of 8.4 mg 3 min/L is needed to achieve a four-orders-of-magnitude (“4 log” or
“99.99%”) inactivation of viruses in an aqueous medium at 25 8C.
Chemical mechanism of virus inactivation: reaction of ClO2 with amino acid residues
In 1986, Noss et al. [19] proved that the inactivation of bacterial virus f2 by ClO2 was due to its
reactions with the viral capsid proteins, and almost no inactivation of the infectious viral RNA
occurred [8] when that was treated with ClO2 separately. They found [19], however, that three
discrete chemical moieties in the viral protein, namely the cysteine, tyrosine, and tryptophan
amino acid residues were able to react with ClO2 rapidly. In 1987, Tan et al. [28] tested the
reactivity of ClO2 on 21 free amino acids. ClO2 reacted only with six amino acids dissolved in 0.1
M sodium phosphate buffer, pH 6.0. The reaction with cysteine, tryptophan, and tyrosine was
too rapid to be followed by their technique. Three further amino acids (histidine, hydroxy-
proline, and proline) reacted with ClO2 much more slowly, at a measurable rate.
The reactivity of the three fast-reacting amino acids (cysteine [12], tyrosine [17], and
tryptophan [27]) was studied in Margerum's laboratory between 2005 and 2008. They found
that cysteine had the highest reactivity among these amino acids. From their experimental data
they calculated second order-rate constants (at pH 7.0, 25 8C and 1 M ionic strength) and
obtained the following sequence: cysteine 6.9 3 106 M1 s1 >> tyrosine 1.3 3 105 M1 s1 >
tryptophan 3.4 3 104 M1 s1 >> guanosine 50-monophosphate 4.5 3 102 M1 s1. (They
studied guanosine 50-monophosphate [18] as a model compound for guanine in nucleic acids.
Data presented here are taken from Table 3 of ref. [18]).
In 2007, Ogata [22] found that the antimicrobial activity of ClO2 is based on denaturation of
certain proteins, which is primarily due to the oxidative modification of the tryptophan and
tyrosine residues of the two model proteins (bovine serum albumin and glucose-6-phosphate
dehydrogenase) used in his experiments. In 2012, it was again Ogata who showed [23] that the
inactivation of influenza virus by ClO2 was caused by oxidation of a tryptophan residue (W153)
in hemagglutinin (a spike protein of the virus), thereby abolishing its receptor-binding ability.
In this context it is interesting to remark that the spike protein of the new coronavirus
SARS_CoV-2 contains 54 tyrosine, 12 tryptophan, and 40 cysteine residues [29]. If we assume
that in an aqueous solution all of these residues are able to react with ClO2 just like the free
amino acids, then the inactivation of the viruses can be extremely rapid even in a very dilute
(e.g., in a 0.1 mg/L) ClO2 solution.
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Although chlorinedioxide in itself is a gas, it is highly soluble in water. When both air and water
are present, ClO2 is distributed between the two phases in an equilibrium ratio determined by
the temperature. This distribution coefficient of ClO2 was determined by Ishi [11] in 1958. The
distribution coefficient, g 5 [ClO2]G/[ClO2]L gives the ratio of the concentrations expressed in
the same units in the gas and the aqueous phases (e.g., g/L) and changes as a function of the
temperature. For example, at 20 8C g 5 0.0316, indicating that in equilibrium 1 cm3 aqueous
phase contains (0.0316)1 5 31.6 times more ClO2 molecules than 1 cm
3 gas phase.
In practice, the concentrations in the two phases are usually given in ppm. However, these
dimensionless numbers are defined in a different way in the gas and liquid phases as ppm (V/V)
and ppm (m/m), respectively. Therefore, for practical purposes, we need a distribution coeffi-
cient, which gives the ratio between these concentrations. Straightforward calculation yields that
the distribution coefficient in terms of ppm is 357 times the distribution coefficient in terms of
(g/L), so at 20 8C gppm 5 11.3. Thus, the following formula can be used to calculate the ClO2
concentration of the gas phase being in equilibrium with a ClO2 solution at 20 8C:
½ClO2gas in ppmðV=VÞ ¼ 11:33 ½ClO2aq in ppmðm=mÞ
Inactivating viruses with ClO2 in gas phase
The virus-inactivating reactions (the reactions of ClO2 with the three amino acids) take place in
an aqueous medium; consequently, ClO2 can inactivate microbes in their wet state only.
Therefore, ClO2 gas that is moisturized can be an ideal agent against viruses both in their wet
and dry states. Viruses that are carried by water droplets could be easily inactivated even by
ClO2 gas owing to the high solubility of ClO2 in water [11]. A dry ClO2 gas would be inap-
propriate as the water content of the aqueous droplet could evaporate, and in the absence of
aqueous medium the reactions of ClO2 slow down extremely. Indeed, Morino et al. [16] reported
that when applying a low concentration of ClO2 in the gas phase against FCV in dry state,
atmospheric moisture – at least a 75–85% relative humidity – is indispensable to inactivate
viruses. The advantage of using a moisturized ClO2 gas is that its water content is also able to
wet viruses in dry environment. Most viruses are found on hard surfaces indoor, but a small
fraction of viruses are “airborn”, attached to dust particles, which can also carry a single microbe
or an aggregate of microbes. Therefore, it is a prerequisite of an effective disinfection that all
microbes in all parts of the room should be wet and should be in contact with ClO2. If enough
aqueous ClO2 solution is sprayed into the room, the droplets will saturate the atmosphere with
water vapor everywhere, moreover, the atmosphere will also contain gaseous ClO2 everywhere.
The great advantage of this method is that H2O and ClO2 molecules of the gas phase can reach
the microbes in every small corner of the room. Finely dispersed water droplets containing
dissolved ClO2 can create an advantageous environment to maintain such conditions for a
longer time.
This method using high ClO2 concentration allows fast disinfection of rooms when people
are not present, e.g., intensive care units, buildings used as quarantine, or public transport
vehicles. However, the application of ClO2 gas is limited when people are present, as it is
harmful for humans and animals above certain concentrations. The US Occupational Safety and
Health Administration (OSHA) limits the concentration of ClO2 gas allowed in workplace air to
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0.3 ppm Short-Term Exposure Limit (STEL) only for a 15-min period [30].
Previous research on preventing viral infections with gaseous ClO2
Ogata [21] realized first that ClO2 is able to inactivate viruses even under the 0.1 ppm (OSHA
TWA) limit that is in concentrations which are not harmful to humans. In 2008, Ogata and
Shibata [25] demonstrated that infection of mice with influenza A virus applied in an aerosol
can be prevented by ClO2 gas present at 0.03 ppm concentration in the air, which is only 30% of
the permissible TWA exposure level for humans at a workplace. They concluded that “ClO2 gas
could, therefore, be useful as a preventive tool against influenza in places of human activity
without necessitating evacuation.” They have even made attempts to decrease the incidence of
flue infections among schoolchildren by applying low concentrations of ClO2 gas in a classroom
[24].
In spite of these promising early results we are not aware of any wider-scale application of
this method in the last decade. There are two problems which could hinder the widespread
adoption of this method:
1. With the technique applied by the above-cited authors it is not an easy task to achieve and
maintain a very low ClO2 concentration in a large space and for a long time, which is a
prerequisite of achieving a satisfactory level of virus inactivation.
2. It is not understood why low ClO2 levels are not harmful to humans or animals and still
effective against viruses.
Size selective effect of ClO2
Although cysteine, tyrosine, and tryptophan residues can also be found in human tissues, ClO2
is much less toxic for humans or animals than for microbes (bacteria, fungi, and viruses).
Noszticzius et al. [20] found that the main reason for this selectivity between humans and
microbes is based not on their different biochemistries but on their different sizes. Based on
experiments and calculations using a reaction-diffusion model Noszticzius et al. [20] found that
the killing time of a living organism is proportional to the square of its characteristic size (e.g., its
diameter), thus small ones will be killed extremely fast. Their calculations indicated that a
bacterium 1 mm in diameter would be killed in a 300 mg/L ClO2 solution within 3 ms, and even
in a much more dilute, 0.25 mg/L ClO2 solution it would be eliminated in only 3.6 s. During this
time, ClO2 reaches all parts of the cell and kills it by destroying its cysteine-, tyrosine-, and
tryptophan-containing proteins, which are essential for life processes.
The protective role of glutathione against ClO2 oxidation in a living cell
According to Ison et al. [12] glutathione reacts with ClO2 at a rate, which is even higher than the
rate of the very fast ClO2 – cysteine reaction. When ClO2 contacts a living cell containing
glutathione, at first the ClO2 concentration remains very low even at the point of entry into the
cell due to this rapid reaction. As a small molecule, glutathione can also diffuse rapidly to the
point of entry from other parts of the cell consuming most of the ClO2 there, and preventing it
from reaching the cysteine, tyrosine, and tryptophan residues of the proteins in the bulk of the
cytoplasm. Consequently, the initial low ClO2 concentration cannot make too much harm.
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dant) capacity even if the cell produces such antioxidants continuously. At this point, ClO2 can
enter into the previously protected zones of the cell and react with the reactive amino acid
residues, causing denaturation of the affected proteins and ultimately cell death.
The effect of glutathione and other small antioxidant molecules present in living cells was
not taken into account in the theoretical calculations of Noszticzius et al. [20]. Their experi-
ments were done on a non-living and washed animal membrane, where membrane-fixed
reactive proteins were present, but glutathione and other small molecules were absent. A living
cell, however, continuously produces these antioxidants, thus their role cannot be neglected.
Indeed, looking at the experimentally measured disinfection dynamics of a 0.25 mg/L ClO2
solution against Escherichia coli bacteria [2] we can see a disinfection rate, which is surprisingly
fast but still about one order of magnitude slower than the theoretical estimate. It is reasonable
to assume that the delaying effect of these small reducing molecules is responsible for that
deviation.
Protection of human tissues against the oxidative effect of ClO2
Human cells also contain glutathione in mM concentrations, as well as other antioxidants like
vitamin C and E, which work together with glutathione to reduce ClO2 [7]. As a human cell is
much larger than a bacterium, consequently its glutathione reserve and glutathione production
potential are also greater, so even an isolated human cell can survive much longer in a ClO2
environment than a planktonic bacterium. Considering that human cells are not isolated but
form tissues, their glutathione stock may be many orders of magnitude greater than that of a
planktonic bacterium. Additionally, in multicellular organisms circulation transports antioxi-
dants continuously to the cells of the tissue affected by a ClO2 attack, helping them to survive.
This strengthens the size-selectivity effect, and explains the surprising observation [15] that
ClO2 solutions that are able to kill planktonic bacteria in a fraction of a second may be
consumed, because they are safe for humans to drink in a small amount (e.g., drinking 1 L of 24
mg/L ClO2 solution in two portions on a single day caused no observable effects in humans
[15]).
The effect of ClO2 on the lung
While human tissues are not very sensitive to ClO2 in general, lungs should be considered
differently. This is because the interalveolar septum separating the airspace of an alveolus from
the blood stream of a capillary lumen is very thin. That diffusion barrier in the human lung is a
mere 2 mm thick [1] in order to facilitate an efficient diffusional exchange of oxygen and carbon
dioxide between the air and blood. The alveolus is covered by a thin layer of lining fluid called
epithelial lung lining fluid (ELF) or hypophase. The ELF is only 0.2 mm thick in rat alveoli [1,
13]. It contains glutathione [3] and other antioxidants such as ascorbic and uric acids [5]. It is
remarkable, that the ascorbic acid concentration is 2.5 times, and the glutathione concentration
is more than 100 times higher in the ELF than in the plasma. The normal function of these non-
enzymatic antioxidants in the ELF is to protect the epithelial cells from reactive oxygen species
(ROS) like superoxide radicals or hydrogen peroxide, which are toxic products of the meta-
bolism. They can also defend the lung against other toxic gases such as ozone (O3), nitrogen
dioxide (NO2) or ClO2. However, high amounts of ClO2 can consume all reducing agents in the
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damage to these cells. It is known that higher concentrations of ClO2 gas can be lethal. However,
it is reasonable to assume that the effect of ClO2 on the lung depends not only on its con-
centration in the gas phase but also on the contact time. Thus, when considering the impact of
ClO2 on the lung, it would be logical to regard the CT (concentration) 3 (contact time) product
in a similar way as in the case of the microbes.
Estimating the inactivation time of viruses
In the case of viruses, the inactivation mechanism differs from that of bacteria or other cells. It is
feasible to assume that the inactivation time of a virus is probably much shorter than the
inactivation time of a bacterium under the same conditions (ClO2 concentration, temperature,
etc.). The following arguments support this assumption:
1. Viruses are about one order of magnitude smaller than bacteria e.g., the diameter of SAR-
S_CoV-2 is about 120 nm [9]. The killing time of a virus as introduced in [20] would be 1–2
orders of magnitude shorter than that of a bacterium, i.e., the diffusion-controlled reaction
with ClO2 would happen on a shorter time scale in the entire volume of the virus.
2. It is not necessary for ClO2 gas to penetrate the virus in order to inactivate it. It is enough if
ClO2 reacts with one or some of the cysteine, tyrosine, and tryptophan amino acid residues of
the spike, which are located on the surface of the virus. This means that the theoretical
approach of ref. [20] overestimates the inactivation time of viruses. On the one hand, because
diffusion is extremely fast over a 0.1 mm length scale, thus probably it is not limiting the rate
of the reactions. On the other hand, ClO2 can reach a large part of the reactive amino acid
residues of the spike without permeating through the protein envelope of the virus.
3. Viruses do not contain protective small molecular thiols like glutathione or other small
molecular protective metabolic products, because viruses have no metabolism. In this respect
viruses should be much more vulnerable than bacteria to an attack by ClO2.
These facts all suggest that once ClO2 contacts the surface of a virus, its inactivation is quick.
However, a virus ready to infect a cell is typically in aqueous phase, e.g., in a fluid droplet, or in the
epithelial lining fluid covering the mucous membranes. The size of these aqueous phases is much
larger than that of the virus. Therefore, in such cases, the rate-limiting step probably is the diffusion of
ClO2 in the water and the reaction with other substances. The time required to inactivate the virus
itself would be short compared to the time needed to transport enough ClO2 molecules to the virus.
SUGGESTIONS FOR PREVENTING THE SPREAD OF VIRAL INFECTIONS
USING ClO2
Based on the previous arguments, some propositions will now be put forward on how aqueous
ClO2 solutions could be applied for global and local (personal) disinfection purposes. Many of
these propositions are based on hypotheses, and therefore can only be applied after careful
research. It is a goal of the present work to initiate research to check these hypotheses and
proposals experimentally, which could lead to new applications of high-purity ClO2 solutions
against viral or other infections. These ideas might be further matured in time, but due to the
threat of a global pandemic, we have chosen to move fast.
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Disinfection of air spaces, hard surfaces, and persons simultaneously with aqueous ClO2
solutions. What we are proposing here is basically the same idea what has been already pro-
posed by Ogata et al. [21, 24, 25]: it is possible to create ClO2 atmospheres which can be safe for
humans but at the same time harmful for microbes. There are differences, however, between
their proposals and ours. Ogata's group regarded the ClO2 concentration (C) of the atmosphere
as the sole important parameter of the treatment. They proposed to apply a ClO2 concentration
below the 0.1 ppm (V/V) OSHA limit, for a time that is necessary to inactivate the microbes.
With such a method, however, the necessary contact time (T) can be very long. Here we suggest
regarding the CT product as the parameter of disinfection. In this way it is possible to apply
ClO2 concentrations above the OSHA limit but for a limited time only. The advantage of this
method is that as higher C values are applied, the necessary contact times can be much shorter.
The idea will be illustrated by a numerical example below.
Another important difference is that Ogata's method focuses mostly on the role of the ClO2
gas, whereas we emphasize the importance of the simultaneous usage of ClO2 and H2O gases, as
confirmed by the observations of Morino et al. [16]. For this purpose, we suggest a new way of
creating a ClO2 atmosphere: to apply aqueous ClO2 solutions which can establish equilibrium
ClO2 and H2O concentrations in the atmosphere, when these are sprayed into the air. Aqueous
solutions are also easier to handle than to maintain stable and very low ClO2 levels in
continuous gas streams.
It is advisable to apply high-purity ClO2 solutions for spraying to avoid any unwanted side
effects to the persons or the surfaces treated. High-purity ClO2 solutions evaporate without any
residue or trace.
An illustrative numerical example. Let us assume that we want to disinfect a closed space by
spraying some aqueous stock ClO2 solution into it. The equilibrium ClO2 concentration cair in
the gas and cw,e in the liquid phase can be calculated from the vapor-liquid equilibrium dis-
tribution measured by Ishi [11]:
g ¼ cair
cw;e
and from the component balance for ClO2:
Vw$cw0 ¼ Vw$cw;e þ Vair$cair
where Vair is the volume to be disinfected, Vw is the volume of the ClO2 stock solution, and cw0 is
its ClO2 concentration.
With the help of the above two equations cw;e can be calculated as
cw;e ¼ cw0
1þ g$VairVw
Suppose we apply Vw 5 20 mL of cw0 5 40 ppm (m/m) aqueous stock ClO2 solution in a
Vair 5 1 m
3 closed space.
At 20 8C the value of the distribution coefficient is g 5 0.0316 (data of Ishi [11]) when all
concentrations are given in the same units (e.g., in mg/L), and it is gppm 5 11.3 (see section ClO2
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phases, respectively. Substituting our data the results are
cw;e ¼ 0:025 ppmðm=mÞ;
cair ¼ gppmcw;e ¼ 0:29 ppmðV=VÞ
This result is just below the OSHA STEL (Short Term Exposition Limit) value which is 0.30
ppm (V/V) for 15 min. According to OSHA, STEL is the acceptable average exposure over a
short period of time – usually 15 min – as long as the time-weighted average (TWA) is not
exceeded. If a person is exposed to 0.30 ppm for 15 min, and right after that he or she stays in a
ClO2-free atmosphere for 30 min, then the TWA value for this whole 45 min period is just the
acceptable 0.10 ppm. All this means that an exposure of a person to a 0.30 ppm ClO2 atmo-
sphere for 15 min on a single occasion, or even applying that treatment periodically with 30 min
pauses within an 8 h period, should not cause any health problems.
Questions and remarks.
1. It is a major question, whether or not a 15-min stay in a 0.29 ppm (V/V) ClO2 atmosphere is
enough to inactivate the viruses present? Regarding the wet atmosphere we can assume that
the viruses are also wet, or even that they can be found in small water droplets containing
0.025 ppm (m/m) ClO2. We have no direct data for the inactivating time of viruses in such a
solution, but we have an estimated 15 ± 5 s killing time value for an E. coli bacterium in a
0.25 ppm (m/m) ClO2 solution [2]. It is reasonable to assume that the killing time would be
10 times longer in a 10 times more dilute solution, i.e., 150 s 5 2.5 min. As viruses are
probably inactivated faster than bacteria, and 15 min is six times longer than the estimated
2.5 min for E. coli, such a method can be successful, at least in theory.
2. To test such a method, we suggest constructing special disinfecting rooms with larger vol-
ume. Starting such experiments would be highly desirable, because this method could be an
effective nonspecific defense against all types of viruses and could help to contain viral
outbreaks.
Local prevention. Personal disinfection techniques against viral infections
Disinfection of the mouth and the upper respiratory track with gargling. The current epidemic
coronavirus is known to be present in the mouth and both in the upper and lower respiratory tract,
but causes severe infections only in the lower respiratory tract, especially in the lung. The incu-
bation period of the disease is several days, but the virus can often be detected in samples taken
from the upper respiratory tract a few days before symptoms appear. As discussed in a previous
chapter, chlorine dioxide will certainly inactivate the virus. With gargling, the upper respiratory
tract is accessible except for the nasal cavity, but that is also accessible using e.g. nose drops or
impregnated tampons. These parts can be disinfected by rinsing them regularly with high-purity
chlorine dioxide solutions available commercially [31], thus the number of the viruses can be
significantly reduced in the mouth and in the upper respiratory tract. We cannot be sure that such a
treatment would be enough to prevent the development of the illness, as viruses living in other parts
of the body can survive. However, inactivating part of the viruses with such a treatment surely helps
the immune system to fight against the disease. In this respect, it is interesting to remark that
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incidence of upper respiratory tract infections to a statistically significant extent. The effect was
explained by the fact that the drinking water used in the experiments contained 0.5 mg/L of
chlorine, which was used to disinfect the water. We remark here, that in certain places chlorine
dioxide is applied for the disinfection of drinking water instead of chlorine.Disinfection of the lower respiratory track. The first problem is how ClO2 can be safely
introduced into the lower respiratory tract. For this purpose any inhalation technique could be
applied using aerosols of water droplets containing ClO2 [14].
The second and more important problem is how much ClO2 can be inhaled without damaging
the lung? It would be helpful to know the dose of ClO2 that is not yet harmful for the lung. To our
knowledge such direct data are not available in the literature, but can be calculated from other
data. The starting point for such a calculation is the OSHA STEL value [30], according to which
0.30 ppm ClO2 in the workplace atmosphere is tolerable for a 15 min period without any damage.
The volume of air inhaled by a worker during 15 min is 15 times the so-called “minute volume
ventilation” [32]. According to Table 3 of ref. [32], during light activities e.g., when sitting in a car
the minute volume is around 12 L, thus the total inhaled air is about 180 L. In the case of 0.30 ppm
concentration the total inhaled amount of ClO2 is 54 mL, which is (at 20 8C) 2.25 mmol ≈ 0.15 mg
ClO2. Assuming a more vigorous activity it can be two times more, 0.30 mg.
This rough calculation indicates that approximately this is the amount of ClO2, which can be
tolerated by the lung. The OSHA limit probably applied high safety factors, thus the real limit should be
higher.
We suggest that animal experiments should be performed to obtain experimental values for
the pulmonary toxicity of ClO2. Furthermore, it would be important to check in additional
animal experiments, whether ClO2 applied in a nontoxic amount is able to treat infections of the
lung caused by bacteria or viruses.CONCLUSION
In this editorial, we summarized the unique properties of chlorine dioxide, which make it an
ideal and nonspecific antimicrobial agent at concentrations harmless to humans, and we
reviewed previous research on preventing viral infections with gaseous ClO2. Based on this
background, we suggested some novel hypothetical methods using chlorine dioxide to disinfect
rooms, prevent human infection, and slow down viral spread. These are nonspecific methods,
which could be used against any newfound virus as a first line of protection until effective
specific countermeasures are developed.
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